AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cartesian Therapeutics, Inc. Director's Dealing 2018

Jun 20, 2018

Director's Dealing

Opens in your device viewer

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2018-06-15

Reporting Person: Farokhzad Omid (Director)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-15	Stock Option (Right to Buy)	$12.75	A	15404	Acquired	2028-06-14	Common Stock (15404)	Direct

F1: The option vests in full on the earlier of June 15, 2019 or the day immediately prior to the company's 2019 annual meeting of shareholders.